| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Retrospective Study |
| Article Title |
Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shun-Kui Luo, Wei-Hua Hu, Zhan-Jin Lu, Chang Li, Ya-Meng Fan, Qi-Jian Chen, Zai-Shu Chen, Jian-Fang Ye, Shi-Yan Chen, Jun-Lu Tong, Ling-Ling Wang, Jin Mei and Hong-Yun Lu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
81670815 |
| Special Fund for Innovation Strategy of Science and Technology plan of Guangdong province |
2019A030317011 |
| Guangdong Basic and Applied Basic Research Foundation |
2020A1515010124 |
| Guangdong Basic and Applied Basic Research Foundation |
2021A1515010695 |
|
| Corresponding Author |
Hong-Yun Lu, MD, PhD, Chief Doctor, Department of Endocrinology and Metabolism, Zhuhai Hospital Affiliated with Jinan University, No. 79 Kangning Road, Zhuhai 519000, Guangdong Province, China. luhongy@mail.sysu.edu.cn |
| Key Words |
Diabetes; Coronavirus disease 2019; Mortality; Risk factors; Acarbose |
| Core Tip |
Previous studies have shown that diabetes mellitus is a common comorbidity of coronavirus disease 2019 (COVID-19), but the effects of diabetes or antidiabetic medication on the mortality of COVID-19 have not been well described. This retrospective and multiple-center study investigate the outcome of different statuses (with or without comorbidity) and antidiabetic medication use before admission of diabetic after COVID-19. |
| Publish Date |
2021-10-13 08:37 |
| Citation |
Luo SK, Hu WH, Lu ZJ, Li C, Fan YM, Chen QJ, Chen ZS, Ye JF, Chen SY, Tong JL, Wang LL, Mei J, Lu HY. Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study. World J Diabetes 2021; 12(10): 1789-1808 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i10/1789.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i10.1789 |
